Abstract:Thalassaemia is a typically monogenic disease caused by mutations or deletions in the globin gene and has a high prevalence in southern China. Prenatal screening for thalassaemia can be effective in reducing the incidence of thalassaemia. Haematologic parameters of pregnant thalassaemia carriers are diverse and potentially valuable for identifying different types of genotypes. By comparing and evaluating haematological parameters, formulas in the literature, we tried to reveal differences between pregnant women carrying different types of thalassaemia genes. The Mentzer formula (MCV/RBC) showed a strong ability to differentiate thalassaemia genotypes in pregnant women. In addition, combined with haemoglobin electrophoresis HbA2 can further distinguish the -α/αα, αTα/αα, -/αα, β+/N and β0/N groups. HbA2 divides them into two groups. Based on the Mentzer formula, we can further decide which type of thalassaemia to screen (α/β and the subgroups) for genotyping. Therefore, this simpler and more cost-effective workflow has great potential for application in screening pregnant women for thalassaemia carriers.Impact StatementWhat is already known on this subject? Currently, it is known that thalassaemia gene carriers have abnormal blood indicators. Many findings describe their important values in distinguishing thalassaemia and other blood diseases. They combined different metrics as an algorithm to distinguish thalassaemia and iron deficiency anaemia. Prenatal screening is an effective method to reduce the incidence of thalassaemia. The current main method is PCR. Due to technical and financial constraints, many backward places cannot use this technology. The necessity for prenatal screening for thalassaemia has been overlooked.What the results of this study add? Among these algorithms, Mentzer formula revealed differences in haematological parameters during pregnancy between normal individuals and thalassaemia carriers. Combining the HbA2, thalassaemia carriers can be distinguished from normal individuals, including -α/αα, αTα/αα, -/αα, β0/N and β+/N.What are the implications of these findings for clinical practice and/or further research? We provide another tool for these hospitals that donot have Hb electrophoresis test and PCR. Then the clinical doctor can get some evidence and suggest women go to another big hospital for essential tests. It is an excellent suggestion. In the future, we will collect more specific gene types and further investigate their potential relationship using these formulas.

Detection of the Point Mutations of α-Thalassemia by Reverse Dot Blot

Development and clinical validation of a novel detection kit for α-thalassemia in southern Chinese

[Rapid Detection of Non-Deletional Alpha-Thalassemia Mutations by PCR-LIS-SSCP].

A Simple, Rapid, and Highly Sensitive Electrochemical DNA Sensor for the Detection of α- and β-Thalassemia in China

Detection of alpha-thalassemia in China by using multiplex ligation-dependent probe amplification

A Nested Asymmetric PCR Melting Curve Assay for One-Step Genotyping of Nondeletional α-Thalassemia Mutations

Rapid detection of non-deletional mutations causing α-thalassemia by multicolor melting curve analysis

Prenatal diagnosis of beta-thalassemia by reverse dot-blot hybridization in southern China

AB034. Hemoglobinopathies in China and SEA: Rapid Targeted Deep Sequencing for Molecular Screening and Clinical Genotyping in Subjects with Hemoglobinopathies

Accurate detection of α-globin gene copy number variants with two reactions using droplet digital PCR

Mutation spectrum of thalassemia among pre-pregnant adults in the Jiangsu Province by capillary electrophoresis-based multiplex PCR assay

Detection of rare thalassemia mutations using long-read single-molecule real-time sequencing

Third-generation sequencing: A novel tool detects complex variants in the α-thalassemia gene

Gene mutation analysis in 481 suspected patients with thalassemia in certain area

Routine antenatal molecular testing for α-thalassemia at a tertiary referral hospital in China: ten years of experience

Development of a Quantitative Multiplex PCR to Detect Three Common Alpha Thalassemia Deletions

Genetic screening of α-thalassemia fusion gene using routine flow-through hybridization

Analysis of the drawback of the combination of MLPA and gene sequencing technology in detecting thalassemia genes

[Analysis of Gene Detection and Hematological Phenotype of Thalassemia]

Clinical experience using peripheral blood parameters to analyse the mutation type of thalassemia carriers in pregnant women

The Incidence of Thalassemia and the Analysis of Thalassemia-Associated Gene in Children in Guangzhou Region